SCHEMBL4583348

SCHEMBL4583348

c1ccc(C2=C(c3ccccc3)C(c3ccccc3)c3ccccc3O2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
MAPT P10636 3/20 0.46
HTT P42858 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPK1 P28482 2/20 0.41
CYP2C9 P11712 3/20 0.40
GAA P10253 1/20 0.40
NTSR1 P30989 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
CYP2C19 P33261 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
ATM Q13315 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
ESR2 Q92731 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NISCH Q9Y2I1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40368 0.77 CYP2C9 (0.55) LMNAMAPTHTTMEN1KMT2A
SCHEMBL6241456 0.71 CYP2C9 (0.42) LMNAMAPTHTTMEN1KMT2A
SCHEMBL501810 0.71 GAA (0.65) LMNAMAPTHTTMEN1KMT2A
SCHEMBL27927654 0.71 CYP2C9 (0.49) LMNAMAPTHTTMEN1KMT2A
Phosphine SCHEMBL23295992 0.69 GAA (0.63) LMNAMAPTHTTMEN1KMT2A
SCHEMBL2011512 0.68 MAPT (0.35) LMNAMAPTHTTMEN1KMT2A
SCHEMBL18085321 0.68 MAPT (0.53) LMNAMAPTHTTMEN1KMT2A
SCHEMBL25949524 0.68 CYP2C9 (0.42) LMNAMAPTHTTMEN1KMT2A
SCHEMBL24402162 0.68 GAA (0.56) LMNAMAPTHTTMEN1KMT2A
SCHEMBL7556279 0.68 LMNA (0.46) LMNAMAPTMAPK1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9649261-B2 Method of applying makeup to a surface and a kit for implementing such a method L'OREAL (FR) 2017-05-16 US disclosed
EP-1799065-B1 MAKE-UP METHOD USING A MAGNETIC COMPOSITION CONTAINING AT LEAST ONE TINTING AGENT HAVING OPTICAL PROPERTIES WHICH ARE SENSITIVE TO AN EXTERNAL STIMULUS ORÉAL L (FR) 2016-08-17 EP disclosed
US-20130160785-A1 METHOD OF APPLYING MAKEUP TO A SURFACE AND A KIT FOR IMPLEMENTING SUCH A METHOD L'OREAL (FR) 2013-06-27 US disclosed
US-20080241086-A1 Line of cosmetic compositions L'OREAL (FR) 2008-10-02 US disclosed
US-20080124288-A1 Method of Applying Makeup by Means of a Magnetic Composition Incorporating at Least one Coloring Agent Having Optical Properties that are Sensitive to an External Stimulus L"OREAL (FR) 2008-05-29 US disclosed
EP-1923040-A2 Cosmetic composition comprising an interferential pigment and a colouring agent which is sensitive to an external stimulus L'OREAL (FR) 2008-05-21 EP disclosed
US-20080102046-A1 Cosmetic composition L'OREAL (FR) 2008-05-01 US disclosed
US-20080095723-A1 Cosmetic composition L'OREAL (FR) 2008-04-24 US disclosed
EP-1897529-A1 Cosmetic composition L'OREAL (FR) 2008-03-12 EP disclosed
EP-1897591-A2 Cosmetic composition, in particular with iridescent effect L'OREAL (FR) 2008-03-12 EP disclosed
EP-1889599-A1 Make-up composition and process for dark skin L'OREAL (FR) 2008-02-20 EP disclosed
US-20080019933-A1 Method of making-up dark skin L'OREAL (FR) 2008-01-24 US disclosed
EP-1799065-A1 MAKE-UP METHOD USING A MAGNETIC COMPOSITION CONTAINING AT LEAST ONE TINTING AGENT HAVING OPTICAL PROPERTIES WHICH ARE SENSITIVE TO AN EXTERNAL STIMULUS L'Oréal (FR) 2007-06-27 EP disclosed
WO-2006037903-A1 MAKE-UP METHOD USING A MAGNETIC COMPOSITION CONTAINING AT LEAST ONE TINTING AGENT HAVING OPTICAL PROPERTIES WHICH ARE SENSITIVE TO AN EXTERNAL STIMULUS L'OREAL (FR) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080095723-A1 Cosmetic composition CUTA, TYR, LBR LMNA 805/4885MAPT 1765/4885HTT 1613/4885
US-20080124288-A1 Method of Applying Makeup by Means of a Magnetic Composition Incorporating at Least one Coloring Agent Having Optical Properties that are Sensitive to an External Stimulus KRT18, CUTA, MARK1 LMNA 1022/4885MAPT 637/4885HTT 2687/4885
US-20080241086-A1 Line of cosmetic compositions CUTA, TYR, RARA LMNA 562/4885MAPT 2448/4885HTT 2315/4885
US-20080019933-A1 Method of making-up dark skin CUTA, DSG1, TYR LMNA 2071/4885MAPT 1929/4885HTT 1623/4885
US-20080102046-A1 Cosmetic composition CUTA, TYR, S100A10 LMNA 1548/4885MAPT 1033/4885HTT 659/4885
US-20130160785-A1 METHOD OF APPLYING MAKEUP TO A SURFACE AND A KIT FOR IMPLEMENTING SUCH A METHOD CUTA, POLR1C, PRKDC LMNA 1460/4885MAPT 1801/4885HTT 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.